|
SF3B1 haploinsufficiency leads to formation of ring sideroblasts in myelodysplastic syndromes
|
Jul 2012
|
Blood
|
myelodysplastic syndromes (MDS)
|
|
SF3B1 mutations in patients with myelodysplastic syndromes: the mutation is stable during disease evolution
|
Apr 2014
|
Am J Hematol
|
myelodysplastic syndromes (MDS)
|
|
SF3B1 Mutations Negatively Predict for Response to Immunosuppressive Therapy in Myelodysplastic Syndromes
|
Jun 2020
|
Clinical Lymphoma , Myeloma & Leukemia
|
myelodysplastic syndromes (MDS)
|
|
SF3B1-mutant myelodysplastic syndrome as a distinct disease subtype - A Proposal of the International Working Group for the Prognosis of Myelodysplastic Syndromes (IWG-PM)
|
Apr 2020
|
Blood
|
myelodysplastic syndromes (MDS)
|
|
Shelf-life Extension of Azacitidine: Waste and Cost Reduction in the Treatment of Myelodysplastic Syndromes
|
May 2014
|
Leuk Lymphoma
|
myelodysplastic syndromes (MDS)
|
|
Short telomeres: from dyskeratosis congenita to sporadic aplastic anemia and malignancy.
|
Jun 2013
|
Transl Res
|
aplastic anemia
|
|
Short- and long-term benefits of lenalidomide treatment in patients with lower-risk del(5q) myelodysplastic syndromes
|
Oct 2015
|
Ann Oncol
|
myelodysplastic syndromes (MDS)
|
|
Should elderly patients with higher-risk myelodysplastic syndromes undergo allogeneic hematopoietic stem cell transplantation?
|
Oct 2013
|
Expert Rev Hematol
|
myelodysplastic syndromes (MDS)
|
|
Significant hemolysis is not required for thrombosis in paroxysmal nocturnal hemoglobinuria.
|
Mar 2019
|
Haematologica
|
paroxysmal nocturnal hemoglobinuria (PNH)
|
|
Silver lining: reduced relapse with chronic GVHD after transplant for MDS
|
Oct 2020
|
Clinical Cancer Research: an official Journal of the American Association of Cancer Research
|
graft versus host disease (GVHD), myelodysplastic syndromes (MDS)
|
